# Wondfo Biotech

> Wondfo Biotech is a VC fund in Guangzhou backing Medical, Health Care and Big Data. See 7 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Guangzhou, China
- Total investments: 7
- Last investment: Mar 2026
- Lead investor: 57%
- Last updated: Aug 2026
- Website: http://en.wondfo.com.cn

Wondfo Biotech is a VC fund in Guangzhou focused on Medical and Health Care. Wondfo Biotech specializes in providing healthcare products and services. It is a biotech company that develops, manufactures, and markets a variety of rapid diagnostic tests. Its products are used in a clinical test, field test, and personal health management. Founded in 1992, Wondfo Biotech is headquartered in Guangzhou, China.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 29% |
| Health Care | 2 | 29% |
| Big Data | 1 | 14% |
| Hospital | 1 | 14% |
| Robotics | 1 | 14% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 3 | 43% |
| Series A | 2 | 29% |
| Funding Round | 1 | 14% |
| Corporate Round | 1 | 14% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Puyi Biotech | Puyi Biotech is a new generation nanopore gene sequencing technology developer. | $21.8M | Series B | Mar 16, 2026 |  |
| Songshan Lake Industrial | Songshan Lake Industrial is a medical instrument research and development company that offers both R&D and production services. | $17.2M | Corporate Round | Dec 26, 2023 |  |
| Puyi Biotech | Puyi Biotech is a new generation nanopore gene sequencing technology developer. |  |  | May 12, 2023 |  |
| Puyi Biotech | Puyi Biotech is a new generation nanopore gene sequencing technology developer. | $14.4M | Series A | May 12, 2023 |  |
| Medical AI | Medical AI specializes in lung and breast disease imaging diagnosis. In partnership with IBM watson, it has developed a proprietary AI imaging diagnostics platform that is used in over 400 hospitals . | $14M | Series B | Mar 20, 2020 |  |
| Yizhun Intelligent | Yizhun Intelligent is an AI & Robotics company. | $14.1M | Series B | Mar 19, 2020 |  |
| Lilian Information Technology Company | Lilian Information Technology Company is a healthcare big data system developer company. |  | Series A | Dec 29, 2017 |  |

7 of 7 investments shown.

## Co-investors
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund, 3 deals together
- Sanmei Touzi — VC Fund, 3 deals together
- [Qingsong Fund](https://shizune.co/investors/profile/qingsong-fund) — VC Fund, 2 deals together
- [Tsinghua Innovation Ventures](https://shizune.co/investors/profile/shuimu-venture-capital) — VC Fund, 2 deals together
- [The Hina Group](https://shizune.co/investors/profile/the-hina-group) — VC Fund, 2 deals together
- [Bank of China Group Investment](https://shizune.co/investors/profile/bank-of-china-group-investment) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Wondfo Biotech invest in?

Wondfo Biotech invests primarily in Medical, Health Care and Big Data startups, most often at Series B and Series A stage. Most of the 7 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Wondfo Biotech last invest?

The most recent investment recorded for Wondfo Biotech closed in Mar 2026. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co